BDBM50272444 5-chloro-3-(2-oxo-2-(2-(pyrrolidin-1-ylmethyl)-4-(3-(trifluoromethyl)phenylsulfonyl)piperazin-1-yl)ethyl)benzo[d]oxazol-2(3H)-one::CHEMBL503322

SMILES FC(F)(F)c1cccc(c1)S(=O)(=O)N1CCN(C(CN2CCCC2)C1)C(=O)Cn1c2cc(Cl)ccc2oc1=O

InChI Key InChIKey=LSUOAEBJTSMGRB-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50272444   

TargetKappa-type opioid receptor(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50272444(5-chloro-3-(2-oxo-2-(2-(pyrrolidin-1-ylmethyl)-4-(...)
Affinity DataEC50:  2.00E+3nMAssay Description:Agonist activity at human kappa opioid receptor expressed in CHO-K1 cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed